{"id":23280,"date":"2023-09-06T14:33:32","date_gmt":"2023-09-06T21:33:32","guid":{"rendered":"https:\/\/ameripharmaspecialty.com\/?p=23280"},"modified":"2026-03-24T09:57:02","modified_gmt":"2026-03-24T16:57:02","slug":"ivig-and-inflammatory-bowel-disease-ibd","status":"publish","type":"post","link":"https:\/\/ameripharmaspecialty.com\/es\/other-health-conditions\/ivig-and-inflammatory-bowel-disease-ibd\/","title":{"rendered":"IgIV y enfermedad inflamatoria intestinal (EII)"},"content":{"rendered":"<p><span style=\"font-weight: 400;\">IgIV, tambi\u00e9n conocida como <a href=\"https:\/\/ameripharmaspecialty.com\/es\/ivig\/ivig\/\/ivig\/\">inmunoglobulina intravenosa<\/a>, es una terapia farmacol\u00f3gica que contiene una mezcla concentrada de derivados humanos <a href=\"https:\/\/ameripharmaspecialty.com\/es\/ivig\/ivig\/\/immunoglobulins-ig\/\">anticuerpos<\/a>Se utiliza para diversas afecciones, incluyendo trastornos autoinmunes y deficiencias inmunitarias en las que el cuerpo no produce suficientes anticuerpos sanos o destruye los suyos. Adem\u00e1s, la IgIV act\u00faa como estimulante de la respuesta inmunitaria, lo que permite al cuerpo combatir eficazmente las sustancias extra\u00f1as y potenciar su capacidad inmunitaria innata. Esta vers\u00e1til intervenci\u00f3n extiende sus beneficios a personas de todas las edades, abarcando tanto a la poblaci\u00f3n pedi\u00e1trica como a la adulta.<\/span><\/p>\n\n\n\n<div  id=\"call-to-action-86ef060aeb830c49fb529ce9b6ec67b0\" style=\"\" class=\"ct_call_to_action\">\n\t<div class=\"container\">\n\t\t<div class=\"block-wrap cta\">\n\t\t\t<div class=\"block-column\">\n\t\t\t\t<div class=\"cta_headings\">\n\t\t\t\t\t\t\t\t\t\t\t<h4 class=\"cta__heading\">\n\t\t\t\t\t\t\t\u00bfPuede ayudar la IgIV?\t\t\t\t\t\t<\/h4>\n\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t<span class=\"cta__sub__heading\">\n\t\t\t\t\t\t\tInformaci\u00f3n gratuita sobre el tratamiento con IgIV\t\t\t\t\t\t<\/span>\n\t\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t\t\t\t\t\t<span class=\"cta_btn\">\n\t\t\t\t\t\t<a href=\"tel:8777780318\">(877) 778-0318<\/a>\n\t\t\t\t\t\t\t\t\t\t\t<\/span>\n\t\t\t\t\t\t\t<\/div>\n\n\t\t<\/div>\n\t<\/div>\n<\/div>\n\n\n\n<p><span style=\"font-weight: 400;\">Gracias a sus propiedades antiinflamatorias inherentes, la IgIV desempe\u00f1a un papel fundamental en el tratamiento de diversas enfermedades inflamatorias autoinmunes. Entre ellas, se encuentran dolencias como <a href=\"https:\/\/ameripharmaspecialty.com\/es\/ivig\/exploring-ivig-treatment-for-kawasaki-disease\/\">enfermedad de Kawasaki<\/a>La administraci\u00f3n de IgIV alivia la vasculitis, la dermatomiositis y la enfermedad intestinal cr\u00f3nica. Este art\u00edculo explicar\u00e1 c\u00f3mo la IgIV es una herramienta eficaz para mitigar los s\u00edntomas asociados con la enfermedad inflamatoria intestinal (EII).<\/span><span style=\"font-weight: 400;\">.<\/span><\/p>\n\n\n\n<div id=\"ez-toc-container\" class=\"ez-toc-v2_0_83 counter-hierarchy ez-toc-counter ez-toc-custom ez-toc-container-direction\">\n<div class=\"ez-toc-title-container\">\n<span class=\"ez-toc-title-toggle\"><a href=\"#\" class=\"ez-toc-pull-right ez-toc-btn ez-toc-btn-xs ez-toc-btn-default ez-toc-toggle\" aria-label=\"Alternar tabla de contenido\"><span class=\"ez-toc-js-icon-con\"><span class=\"\"><span class=\"eztoc-hide\" style=\"display:none;\">Palanca<\/span><span class=\"ez-toc-icon-toggle-span\"><svg style=\"fill: #999;color:#999\" xmlns=\"http:\/\/www.w3.org\/2000\/svg\" class=\"list-377408\" width=\"20px\" height=\"20px\" viewbox=\"0 0 24 24\" fill=\"none\"><path d=\"M6 6H4v2h2V6zm14 0H8v2h12V6zM4 11h2v2H4v-2zm16 0H8v2h12v-2zM4 16h2v2H4v-2zm16 0H8v2h12v-2z\" fill=\"currentColor\"><\/path><\/svg><svg style=\"fill: #999;color:#999\" class=\"arrow-unsorted-368013\" xmlns=\"http:\/\/www.w3.org\/2000\/svg\" width=\"10px\" height=\"10px\" viewbox=\"0 0 24 24\" version=\"1.2\" baseprofile=\"tiny\"><path d=\"M18.2 9.3l-6.2-6.3-6.2 6.3c-.2.2-.3.4-.3.7s.1.5.3.7c.2.2.4.3.7.3h11c.3 0 .5-.1.7-.3.2-.2.3-.5.3-.7s-.1-.5-.3-.7zM5.8 14.7l6.2 6.3 6.2-6.3c.2-.2.3-.5.3-.7s-.1-.5-.3-.7c-.2-.2-.4-.3-.7-.3h-11c-.3 0-.5.1-.7.3-.2.2-.3.5-.3.7s.1.5.3.7z\"\/><\/svg><\/span><\/span><\/span><\/a><\/span><\/div>\n<nav><ul class='ez-toc-list ez-toc-list-level-1' ><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-1\" href=\"https:\/\/ameripharmaspecialty.com\/es\/other-health-conditions\/ivig-and-inflammatory-bowel-disease-ibd\/#What_Is_Inflammatory_Bowel_Disease_IBD_and_Its_Symptoms\" >\u00bfQu\u00e9 es la enfermedad inflamatoria intestinal (EII) y sus s\u00edntomas?&nbsp;<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-2\" href=\"https:\/\/ameripharmaspecialty.com\/es\/other-health-conditions\/ivig-and-inflammatory-bowel-disease-ibd\/#IVIG_and_Inflammatory_Bowel_Disease_How_IVIG_Helps_Manage_Symptoms\" >IgIV y enfermedad inflamatoria intestinal: c\u00f3mo la IgIV ayuda a controlar los s\u00edntomas&nbsp;<\/a><ul class='ez-toc-list-level-3' ><li class='ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-3\" href=\"https:\/\/ameripharmaspecialty.com\/es\/other-health-conditions\/ivig-and-inflammatory-bowel-disease-ibd\/#Immunomodulation\" >Inmunomodulaci\u00f3n<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-4\" href=\"https:\/\/ameripharmaspecialty.com\/es\/other-health-conditions\/ivig-and-inflammatory-bowel-disease-ibd\/#Cytokine_Regulation\" >Regulaci\u00f3n de citocinas&nbsp;<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-5\" href=\"https:\/\/ameripharmaspecialty.com\/es\/other-health-conditions\/ivig-and-inflammatory-bowel-disease-ibd\/#Anti-Inflammatory_Properties\" >Propiedades antiinflamatorias<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-6\" href=\"https:\/\/ameripharmaspecialty.com\/es\/other-health-conditions\/ivig-and-inflammatory-bowel-disease-ibd\/#Regulating_Immune_Cells\" >Regulaci\u00f3n de las c\u00e9lulas inmunes<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-7\" href=\"https:\/\/ameripharmaspecialty.com\/es\/other-health-conditions\/ivig-and-inflammatory-bowel-disease-ibd\/#Mucosal_Healing\" >Curaci\u00f3n de la mucosa<\/a><\/li><\/ul><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-8\" href=\"https:\/\/ameripharmaspecialty.com\/es\/other-health-conditions\/ivig-and-inflammatory-bowel-disease-ibd\/#Studies_on_IVIG_and_Inflammatory_Bowel_Disease\" >Estudios sobre IgIV y enfermedad inflamatoria intestinal&nbsp;<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-9\" href=\"https:\/\/ameripharmaspecialty.com\/es\/other-health-conditions\/ivig-and-inflammatory-bowel-disease-ibd\/#The_Ideal_Candidate_for_IVIG_Treatment\" >El candidato ideal para el tratamiento con IgIV&nbsp;&nbsp;&nbsp;<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-10\" href=\"https:\/\/ameripharmaspecialty.com\/es\/other-health-conditions\/ivig-and-inflammatory-bowel-disease-ibd\/#Which_Patients_With_Inflammatory_Bowel_Disease_Should_Not_Take_IVIG\" >\u00bfQu\u00e9 pacientes con enfermedad inflamatoria intestinal no deben tomar IgIV?&nbsp;<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-11\" href=\"https:\/\/ameripharmaspecialty.com\/es\/other-health-conditions\/ivig-and-inflammatory-bowel-disease-ibd\/#Side_Effects_Of_IVIG\" >Efectos secundarios de la IgIV&nbsp;<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-12\" href=\"https:\/\/ameripharmaspecialty.com\/es\/other-health-conditions\/ivig-and-inflammatory-bowel-disease-ibd\/#Risks_of_IVIG\" >Riesgos de la IgIV&nbsp;<\/a><\/li><\/ul><\/nav><\/div>\n<h2 class=\"wp-block-heading\"><span class=\"ez-toc-section\" id=\"What_Is_Inflammatory_Bowel_Disease_IBD_and_Its_Symptoms\"><\/span><span style=\"font-weight: 400;\">\u00bfQu\u00e9 es la enfermedad inflamatoria intestinal (EII) y sus s\u00edntomas?&nbsp;<\/span><span class=\"ez-toc-section-end\"><\/span><\/h2>\n\n\n\n<p><span style=\"font-weight: 400;\">La enfermedad inflamatoria intestinal (EII) es una inflamaci\u00f3n persistente del tracto gastrointestinal (TGI). La EII se refiere a dos enfermedades: la colitis ulcerosa y la enfermedad de Crohn.<\/span><\/p>\n\n\n\n<p><span style=\"font-weight: 400;\">La colitis ulcerosa es la inflamaci\u00f3n del colon (el revestimiento interno del intestino grueso) que se cree es causada por reacciones anormales del sistema inmunitario. Sin embargo, otros factores, adem\u00e1s de los efectos inmunitarios, pueden causar colitis ulcerosa, como factores gen\u00e9ticos y desencadenantes ambientales como el estr\u00e9s, la depresi\u00f3n, el tabaquismo y el consumo de medicamentos.<\/span><\/p>\n\n\n\n<p><span style=\"font-weight: 400;\">Algunos de los s\u00edntomas comunes de la colitis ulcerosa incluyen:<\/span><\/p>\n\n\n\n<ul class=\"wp-block-list\">\n<li><span style=\"font-weight: 400;\">Dolor abdominal<\/span><\/li>\n\n\n\n<li><span style=\"font-weight: 400;\">Sangre en las heces<\/span><\/li>\n\n\n\n<li><span style=\"font-weight: 400;\">Diarrea<\/span><\/li>\n\n\n\n<li><span style=\"font-weight: 400;\">V\u00f3mitos&nbsp;<\/span><\/li>\n\n\n\n<li><span style=\"font-weight: 400;\">Fiebre<\/span><\/li>\n\n\n\n<li><span style=\"font-weight: 400;\">P\u00e9rdida de peso<\/span><\/li>\n<\/ul>\n\n\n\n<p><span style=\"font-weight: 400;\">La enfermedad de Crohn es otra enfermedad inflamatoria autoinmune del tracto gastrointestinal, que afecta diferentes \u00e1reas del tracto gastrointestinal, desde el est\u00f3mago hasta el ano. La respuesta normal del cuerpo a cualquier enfermedad o da\u00f1o, incluidas las enfermedades autoinmunes, es la inflamaci\u00f3n. En la enfermedad de Crohn, el sistema inmunitario ataca las c\u00e9lulas sanas, lo que desencadena inflamaci\u00f3n y causa \u00falceras e hinchaz\u00f3n en el tracto gastrointestinal.&nbsp;<\/span><\/p>\n\n\n\n<p><span style=\"font-weight: 400;\">Los s\u00edntomas de la enfermedad de Crohn incluyen:<\/span><\/p>\n\n\n\n<ul class=\"wp-block-list\">\n<li><span style=\"font-weight: 400;\">diarrea severa<\/span><\/li>\n\n\n\n<li><span style=\"font-weight: 400;\">Dolor abdominal<\/span><\/li>\n\n\n\n<li><span style=\"font-weight: 400;\">Fatiga<\/span><\/li>\n\n\n\n<li><span style=\"font-weight: 400;\">Desnutrici\u00f3n<\/span><\/li>\n\n\n\n<li><span style=\"font-weight: 400;\">P\u00e9rdida de peso<\/span><\/li>\n\n\n\n<li><span style=\"font-weight: 400;\">Sangre en las heces<\/span><\/li>\n\n\n\n<li><span style=\"font-weight: 400;\">disminuci\u00f3n del apetito<\/span><\/li>\n\n\n\n<li><span style=\"font-weight: 400;\">Fiebre&nbsp;<\/span><\/li>\n<\/ul>\n\n\n\n<h2 class=\"wp-block-heading\"><span class=\"ez-toc-section\" id=\"IVIG_and_Inflammatory_Bowel_Disease_How_IVIG_Helps_Manage_Symptoms\"><\/span><span style=\"font-weight: 400;\">IgIV y enfermedad inflamatoria intestinal: c\u00f3mo la IgIV ayuda a controlar los s\u00edntomas&nbsp;<\/span><span class=\"ez-toc-section-end\"><\/span><\/h2>\n\n\n\n<p><span style=\"font-weight: 400;\">La IgIV se utiliza a menudo en personas que no han respondido a otros tratamientos tradicionales para la enfermedad inflamatoria intestinal grave, como la enfermedad de Crohn o la colitis ulcerosa. Entre el 10% y el 20% de las personas con enfermedad inflamatoria intestinal no responden a los tratamientos primarios, y en estos casos puede ser necesaria la terapia con inmunoglobulinas. La IgIV ayuda a controlar los s\u00edntomas de la EII mediante los siguientes mecanismos:<\/span><\/p>\n\n\n\n<h3 class=\"wp-block-heading\"><span class=\"ez-toc-section\" id=\"Immunomodulation\"><\/span><span style=\"font-weight: 400;\">Inmunomodulaci\u00f3n<\/span><span class=\"ez-toc-section-end\"><\/span><\/h3>\n\n\n\n<p><span style=\"font-weight: 400;\">Adem\u00e1s de ayudar a modificar las respuestas inmunes y evitar que el sistema inmunol\u00f3gico ataque a las c\u00e9lulas sanas, la IgIV tambi\u00e9n contiene una variedad de anticuerpos saludables concentrados de origen humano, lo que reduce la inflamaci\u00f3n del tracto gastrointestinal.<\/span><\/p>\n\n\n\n<h3 class=\"wp-block-heading\"><span class=\"ez-toc-section\" id=\"Cytokine_Regulation\"><\/span><span style=\"font-weight: 400;\">Regulaci\u00f3n de citocinas&nbsp;<\/span><span class=\"ez-toc-section-end\"><\/span><\/h3>\n\n\n\n<p><span style=\"font-weight: 400;\"><a href=\"https:\/\/www.cancer.org\/cancer\/managing-cancer\/treatment-types\/immunotherapy\/cytokines.html#:~:text=Cytokines%20are%20small%20proteins%20that,body's%20immune%20and%20inflammation%20responses.\">Citocinas<\/a> Son mol\u00e9culas de se\u00f1alizaci\u00f3n secretadas por las c\u00e9lulas inmunitarias que intervienen en el control de la inflamaci\u00f3n. La IgIV tambi\u00e9n puede influir en la creaci\u00f3n, la actividad y la cantidad de citocinas, lo que contribuye a mejorar el sistema inmunitario y a reducir la inflamaci\u00f3n.<\/span><\/p>\n\n\n\n<h3 class=\"wp-block-heading\"><span class=\"ez-toc-section\" id=\"Anti-Inflammatory_Properties\"><\/span><span style=\"font-weight: 400;\">Propiedades antiinflamatorias<\/span><span class=\"ez-toc-section-end\"><\/span><\/h3>\n\n\n\n<p><span style=\"font-weight: 400;\">La inmunoglobulina intravenosa (IVIG) est\u00e1 compuesta por una mezcla de anticuerpos, que incluyen IgG, IgA e IgM, que poseen propiedades antiinflamatorias y regulan la respuesta inmunitaria contra la inflamaci\u00f3n. Al disminuir la inflamaci\u00f3n, la IVIG ayuda a mitigar los s\u00edntomas de la enfermedad inflamatoria intestinal (EII), como diarrea, fiebre, dolor abdominal y fatiga.<\/span><\/p>\n\n\n\n<div  id=\"call-to-action-ef0438a4d18a823772a0cf132cc8991c\" style=\"\" class=\"ct_call_to_action\">\n\t<div class=\"container\">\n\t\t<div class=\"block-wrap cta\">\n\t\t\t<div class=\"block-column\">\n\t\t\t\t<div class=\"cta_headings\">\n\t\t\t\t\t\t\t\t\t\t\t<h4 class=\"cta__heading\">\n\t\t\t\t\t\t\tHabla con un especialista \t\t\t\t\t\t<\/h4>\n\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t<span class=\"cta__sub__heading\">\n\t\t\t\t\t\t\tAcerca de la asistencia para copagos\t\t\t\t\t\t<\/span>\n\t\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t\t\t\t\t\t<span class=\"cta_btn\">\n\t\t\t\t\t\t<a href=\"#form\">Programar una consulta<\/a>\n\t\t\t\t\t\t\t\t\t\t\t<\/span>\n\t\t\t\t\t\t\t<\/div>\n\n\t\t<\/div>\n\t<\/div>\n<\/div>\n\n\n\n<h3 class=\"wp-block-heading\"><span class=\"ez-toc-section\" id=\"Regulating_Immune_Cells\"><\/span><span style=\"font-weight: 400;\">Regulaci\u00f3n de las c\u00e9lulas inmunes<\/span><span class=\"ez-toc-section-end\"><\/span><\/h3>\n\n\n\n<p><span style=\"font-weight: 400;\">Como la IgIV estimula el sistema inmunol\u00f3gico utilizando una variedad de anticuerpos beneficiosos, tambi\u00e9n regula las funciones de varias c\u00e9lulas inmunes como <a href=\"https:\/\/en.wikipedia.org\/wiki\/Dendritic_cell\">c\u00e9lulas dendr\u00edticas<\/a>, c\u00e9lulas T y c\u00e9lulas B. Esta doble acci\u00f3n ayuda a disminuir la liberaci\u00f3n de citocinas proinflamatorias al tiempo que promueve la secreci\u00f3n y producci\u00f3n de citocinas antiinflamatorias.<\/span><\/p>\n\n\n\n<h3 class=\"wp-block-heading\"><span class=\"ez-toc-section\" id=\"Mucosal_Healing\"><\/span><span style=\"font-weight: 400;\">Curaci\u00f3n de la mucosa<\/span><span class=\"ez-toc-section-end\"><\/span><\/h3>\n\n\n\n<p><span style=\"font-weight: 400;\">La IgIV ayuda a la curaci\u00f3n de la mucosa y estimula el sistema inmunol\u00f3gico, mejorando la salud general del tracto gastrointestinal.<\/span><\/p>\n\n\n\n<h2 class=\"wp-block-heading\"><span class=\"ez-toc-section\" id=\"Studies_on_IVIG_and_Inflammatory_Bowel_Disease\"><\/span><span style=\"font-weight: 400;\">Estudios sobre IgIV y enfermedad inflamatoria intestinal&nbsp;<\/span><span class=\"ez-toc-section-end\"><\/span><\/h2>\n\n\n\n<p><span style=\"font-weight: 400;\">Los pacientes con enfermedad inflamatoria intestinal pueden no ser aptos para la terapia farmacol\u00f3gica tradicional o pueden desarrollar tolerancia a algunos f\u00e1rmacos para la EII tras un uso prolongado. En estos casos, se pueden administrar terapias alternativas, como la inmunoglobulina intravenosa, para un tratamiento a corto plazo.&nbsp;<\/span><\/p>\n\n\n\n<p><a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/25993689\/\"><span style=\"font-weight: 400;\">Investigaci\u00f3n<\/span><\/a><span style=\"font-weight: 400;\"> Investigaron los efectos de la IgIV en pacientes con EII y demostraron que la IgIV es segura y efectiva para el tratamiento a corto plazo de la EII en pacientes que est\u00e1n contraindicados a los tratamientos est\u00e1ndar.&nbsp;<\/span><\/p>\n\n\n\n<p><span style=\"font-weight: 400;\">Los medicamentos antiinflamatorios, la terapia biol\u00f3gica, como los anti-TNFa (antifactor de necrosis tumoral alfa), y los inmunosupresores son tratamientos comunes para la enfermedad inflamatoria intestinal. La inmunoglobulina intravenosa (IVIG) reduce los efectos negativos de estos medicamentos en pacientes con intolerancia a ellos y ofrece una opci\u00f3n de tratamiento diferente con un perfil de seguridad distinto.<\/span><\/p>\n\n\n\n<p><span style=\"font-weight: 400;\">Los pacientes con enfermedad inflamatoria intestinal tambi\u00e9n deben realizar modificaciones en su dieta, adem\u00e1s de tomar medicamentos. Estos cambios deben incluir el consumo de alimentos fr\u00edos y evitar comidas especialmente calientes, as\u00ed como otros alimentos que aumenten la producci\u00f3n de heces, como el caf\u00e9, las ciruelas pasas y las frutas y verduras frescas. Dependiendo del estado de salud del paciente, las dosis habituales de IgIV pueden variar entre 400 y 800 mg\/kg cada 4 semanas (al mes).<\/span><\/p>\n\n\n\n<h2 class=\"wp-block-heading\"><span class=\"ez-toc-section\" id=\"The_Ideal_Candidate_for_IVIG_Treatment\"><\/span><span style=\"font-weight: 400;\">El candidato ideal para el tratamiento con IgIV&nbsp;&nbsp;&nbsp;<\/span><span class=\"ez-toc-section-end\"><\/span><\/h2>\n\n\n\n<p><span style=\"font-weight: 400;\">La IgIV no es un tratamiento de primera l\u00ednea ni primario para la EII. El uso de IgIV puede ser ideal para los siguientes candidatos:<\/span><\/p>\n\n\n\n<ul class=\"wp-block-list\">\n<li><span style=\"font-weight: 400;\">Pacientes con uno o m\u00e1s trastornos autoinmunes o deficiencias inmunitarias adem\u00e1s de enfermedad inflamatoria intestinal.<\/span><\/li>\n\n\n\n<li><span style=\"font-weight: 400;\">Candidatos cuyas enfermedades autoinmunes no se controlan bien con otros tratamientos convencionales.<\/span><\/li>\n\n\n\n<li><span style=\"font-weight: 400;\">Pacientes que no responden o toleran los medicamentos antiinflamatorios.<\/span><\/li>\n<\/ul>\n\n\n\n<h2 class=\"wp-block-heading\"><span class=\"ez-toc-section\" id=\"Which_Patients_With_Inflammatory_Bowel_Disease_Should_Not_Take_IVIG\"><\/span><span style=\"font-weight: 400;\">\u00bfQu\u00e9 pacientes con <\/span><span style=\"font-weight: 400;\">Enfermedad inflamatoria intestinal&nbsp;<\/span><span style=\"font-weight: 400;\">\u00bfNo deber\u00eda tomar IgIV?&nbsp;<\/span><span class=\"ez-toc-section-end\"><\/span><\/h2>\n\n\n\n<p><span style=\"font-weight: 400;\">La IgIV suele estar contraindicada en los siguientes pacientes con enfermedad inflamatoria intestinal:<\/span><\/p>\n\n\n\n<ul class=\"wp-block-list\">\n<li><span style=\"font-weight: 400;\">Pacientes intolerantes a la fructosa.<\/span><\/li>\n\n\n\n<li><span style=\"font-weight: 400;\">Pacientes que tuvieron antecedentes de reacci\u00f3n negativa a inmunoglobulina o IgIV.<\/span><\/li>\n\n\n\n<li><span style=\"font-weight: 400;\">Pacientes que hayan recibido recientemente vacunas vivas, como la del sarampi\u00f3n o las paperas.<\/span><\/li>\n<\/ul>\n\n\n\n<h2 class=\"wp-block-heading\"><span class=\"ez-toc-section\" id=\"Side_Effects_Of_IVIG\"><\/span><span style=\"font-weight: 400;\">Efectos secundarios de la IgIV&nbsp;<\/span><span class=\"ez-toc-section-end\"><\/span><\/h2>\n\n\n<div class=\"wp-block-image\">\n<figure class=\"alignright\"><img loading=\"lazy\" decoding=\"async\" width=\"422\" height=\"281\" src=\"https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2023\/09\/ivig-side-effects.jpg\" alt=\"Senior woman suffering side effects after taking IVIG for inflammatory bowel disease\" class=\"wp-image-23283\" srcset=\"https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2023\/09\/ivig-side-effects.jpg 422w, https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2023\/09\/ivig-side-effects-300x200.jpg 300w, https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2023\/09\/ivig-side-effects-330x220.jpg 330w, https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2023\/09\/ivig-side-effects-86x57.jpg 86w, https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2023\/09\/ivig-side-effects-167x111.jpg 167w, https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2023\/09\/ivig-side-effects-280x186.jpg 280w, https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2023\/09\/ivig-side-effects-370x246.jpg 370w\" sizes=\"auto, (max-width: 422px) 100vw, 422px\" \/><\/figure>\n<\/div>\n\n\n<p><span style=\"font-weight: 400;\">El com\u00fan <a href=\"https:\/\/ameripharmaspecialty.com\/es\/ivig\/understanding-the-common-side-effects-of-ivig-treatment\/\">efectos secundarios de la IgIV<\/a> incluir:<\/span><\/p>\n\n\n\n<ul class=\"wp-block-list\">\n<li><span style=\"font-weight: 400;\">dolores musculares<\/span><\/li>\n\n\n\n<li><span style=\"font-weight: 400;\">Gripe<\/span><\/li>\n\n\n\n<li><span style=\"font-weight: 400;\">N\u00e1useas<\/span><\/li>\n\n\n\n<li><span style=\"font-weight: 400;\">Fiebre<\/span><\/li>\n\n\n\n<li><span style=\"font-weight: 400;\">Enrojecimiento<\/span><\/li>\n<\/ul>\n\n\n\n<p><span style=\"font-weight: 400;\">Estos efectos secundarios ocurren com\u00fanmente durante los primeros 2 d\u00edas de infusi\u00f3n, pero si persisten o se vuelven graves, consulte a su m\u00e9dico inmediatamente.<\/span><\/p>\n\n\n\n<div  id=\"call-to-action-2e1d9369f03fa7f7d930572a6a2fdd62\" style=\"\" class=\"ct_call_to_action\">\n\t<div class=\"container\">\n\t\t<div class=\"block-wrap cta\">\n\t\t\t<div class=\"block-column\">\n\t\t\t\t<div class=\"cta_headings\">\n\t\t\t\t\t\t\t\t\t\t\t<h4 class=\"cta__heading\">\n\t\t\t\t\t\t\tInformaci\u00f3n del tratamiento\u00a0\t\t\t\t\t\t<\/h4>\n\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t<span class=\"cta__sub__heading\">\n\t\t\t\t\t\t\tObtenga autorizaci\u00f3n previa para IgIV\t\t\t\t\t\t<\/span>\n\t\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t\t\t\t\t\t<span class=\"cta_btn\">\n\t\t\t\t\t\t<a href=\"tel:8777780318\">(877) 778-0318<\/a>\n\t\t\t\t\t\t\t\t\t\t\t<\/span>\n\t\t\t\t\t\t\t<\/div>\n\n\t\t<\/div>\n\t<\/div>\n<\/div>\n\n\n\n<h2 class=\"wp-block-heading\"><span class=\"ez-toc-section\" id=\"Risks_of_IVIG\"><\/span><span style=\"font-weight: 400;\">Riesgos de la IgIV&nbsp;<\/span><span class=\"ez-toc-section-end\"><\/span><\/h2>\n\n\n\n<p><span style=\"font-weight: 400;\">Debido a los riesgos y complicaciones inherentes de la IgIV, su uso se vuelve particularmente deseable en casos m\u00e1s graves, donde se ha demostrado que otros mecanismos de acci\u00f3n son inadecuados para controlar las complicaciones de la enfermedad inflamatoria intestinal (EII). <\/span><span style=\"font-weight: 400;\">Los riesgos potenciales de la EII incluyen:<\/span><\/p>\n\n\n\n<ul class=\"wp-block-list\">\n<li><span style=\"font-weight: 400;\">Reacciones a la infusi\u00f3n<\/span><\/li>\n\n\n\n<li><span style=\"font-weight: 400;\">Reacciones al\u00e9rgicas<\/span><\/li>\n\n\n\n<li><span style=\"font-weight: 400;\">Disfunci\u00f3n renal<\/span><\/li>\n\n\n\n<li><span style=\"font-weight: 400;\">Efectos tromb\u00f3ticos&nbsp;<\/span><\/li>\n<\/ul>\n\n\n\n<p><span style=\"font-weight: 400;\">Para reducir los posibles riesgos asociados con la IgIV, es fundamental mantener una actitud vigilante. Esto implica monitorear de cerca s\u00edntomas como hinchaz\u00f3n, dolor o sangrado, as\u00ed como realizar evaluaciones exhaustivas de la funci\u00f3n renal. Esta supervisi\u00f3n es crucial tanto durante como despu\u00e9s de la administraci\u00f3n de IgIV. Si bien la IgIV generalmente se considera segura durante el embarazo y la lactancia, es necesario mantener una conversaci\u00f3n informada con su profesional de la salud. Es importante compartir detalles sobre su historial m\u00e9dico, uso de medicamentos y su afecci\u00f3n antes de comenzar la terapia con inmunoglobulinas.<\/span><\/p>","protected":false},"excerpt":{"rendered":"<p>La IgIV, tambi\u00e9n conocida como inmunoglobulina intravenosa, es un tratamiento farmacol\u00f3gico que contiene una mezcla concentrada de anticuerpos humanos. Se utiliza para diversas afecciones, como trastornos autoinmunes y deficiencias inmunitarias en las que el organismo no produce suficientes anticuerpos sanos o destruye los suyos.<\/p>","protected":false},"author":16,"featured_media":23282,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"om_disable_all_campaigns":false,"_uag_custom_page_level_css":"","footnotes":""},"categories":[4],"tags":[21],"class_list":["post-23280","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-other-health-conditions","tag-dr-martina-mikail"],"acf":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.5 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>IVIG and Inflammatory Bowel Disease (IBD) - AmeriPharma\u00ae Specialty Care<\/title>\n<meta name=\"description\" content=\"This article discusses IVIG and inflammatory bowel disease. Topics include how IVIG helps manage symptoms, side effects, risks, and more.\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/ameripharmaspecialty.com\/es\/other-health-conditions\/ivig-and-inflammatory-bowel-disease-ibd\/\" \/>\n<meta property=\"og:locale\" content=\"es_MX\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"IVIG and Inflammatory Bowel Disease (IBD) - AmeriPharma\u00ae Specialty Care\" \/>\n<meta property=\"og:description\" content=\"This article discusses IVIG and inflammatory bowel disease. Topics include how IVIG helps manage symptoms, side effects, risks, and more.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/ameripharmaspecialty.com\/es\/other-health-conditions\/ivig-and-inflammatory-bowel-disease-ibd\/\" \/>\n<meta property=\"og:site_name\" content=\"AmeriPharma\u00ae Specialty Care\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/ameripharma\/\" \/>\n<meta property=\"article:published_time\" content=\"2023-09-06T21:33:32+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2026-03-24T16:57:02+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2023\/09\/ibd.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"1280\" \/>\n\t<meta property=\"og:image:height\" content=\"853\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"Dr. Martina Mikail, PharmD\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Dr. Martina Mikail, PharmD\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"6 minutos\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/ameripharmaspecialty.com\\\/zh\\\/other-health-conditions\\\/ivig-and-inflammatory-bowel-disease-ibd\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/ameripharmaspecialty.com\\\/zh\\\/other-health-conditions\\\/ivig-and-inflammatory-bowel-disease-ibd\\\/\"},\"author\":{\"name\":\"Dr. Martina Mikail, PharmD\",\"@id\":\"https:\\\/\\\/ameripharmaspecialty.com\\\/es\\\/#\\\/schema\\\/person\\\/1a08790136f47e0a1978629cdfeca933\"},\"headline\":\"IVIG and Inflammatory Bowel Disease (IBD)\",\"datePublished\":\"2023-09-06T21:33:32+00:00\",\"dateModified\":\"2026-03-24T16:57:02+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/ameripharmaspecialty.com\\\/zh\\\/other-health-conditions\\\/ivig-and-inflammatory-bowel-disease-ibd\\\/\"},\"wordCount\":1107,\"publisher\":{\"@id\":\"https:\\\/\\\/ameripharmaspecialty.com\\\/es\\\/#organization\"},\"image\":{\"@id\":\"https:\\\/\\\/ameripharmaspecialty.com\\\/zh\\\/other-health-conditions\\\/ivig-and-inflammatory-bowel-disease-ibd\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/ameripharmaspecialty.com\\\/wp-content\\\/uploads\\\/2023\\\/09\\\/ibd.jpg\",\"keywords\":[\"Dr. Martina Mikail\"],\"articleSection\":[\"Other Health Conditions\"],\"inLanguage\":\"es\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/ameripharmaspecialty.com\\\/zh\\\/other-health-conditions\\\/ivig-and-inflammatory-bowel-disease-ibd\\\/\",\"url\":\"https:\\\/\\\/ameripharmaspecialty.com\\\/zh\\\/other-health-conditions\\\/ivig-and-inflammatory-bowel-disease-ibd\\\/\",\"name\":\"IVIG and Inflammatory Bowel Disease (IBD) - AmeriPharma\u00ae Specialty Care\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/ameripharmaspecialty.com\\\/es\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/ameripharmaspecialty.com\\\/zh\\\/other-health-conditions\\\/ivig-and-inflammatory-bowel-disease-ibd\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/ameripharmaspecialty.com\\\/zh\\\/other-health-conditions\\\/ivig-and-inflammatory-bowel-disease-ibd\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/ameripharmaspecialty.com\\\/wp-content\\\/uploads\\\/2023\\\/09\\\/ibd.jpg\",\"datePublished\":\"2023-09-06T21:33:32+00:00\",\"dateModified\":\"2026-03-24T16:57:02+00:00\",\"description\":\"This article discusses IVIG and inflammatory bowel disease. Topics include how IVIG helps manage symptoms, side effects, risks, and more.\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/ameripharmaspecialty.com\\\/zh\\\/other-health-conditions\\\/ivig-and-inflammatory-bowel-disease-ibd\\\/#breadcrumb\"},\"inLanguage\":\"es\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/ameripharmaspecialty.com\\\/zh\\\/other-health-conditions\\\/ivig-and-inflammatory-bowel-disease-ibd\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"es\",\"@id\":\"https:\\\/\\\/ameripharmaspecialty.com\\\/zh\\\/other-health-conditions\\\/ivig-and-inflammatory-bowel-disease-ibd\\\/#primaryimage\",\"url\":\"https:\\\/\\\/ameripharmaspecialty.com\\\/wp-content\\\/uploads\\\/2023\\\/09\\\/ibd.jpg\",\"contentUrl\":\"https:\\\/\\\/ameripharmaspecialty.com\\\/wp-content\\\/uploads\\\/2023\\\/09\\\/ibd.jpg\",\"width\":1280,\"height\":853,\"caption\":\"Intestine, colon, bowel in doctor hands. Digestive and gastrointestinal diseases concept.\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/ameripharmaspecialty.com\\\/zh\\\/other-health-conditions\\\/ivig-and-inflammatory-bowel-disease-ibd\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/ameripharmaspecialty.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"IVIG and Inflammatory Bowel Disease (IBD)\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/ameripharmaspecialty.com\\\/es\\\/#website\",\"url\":\"https:\\\/\\\/ameripharmaspecialty.com\\\/es\\\/\",\"name\":\"AmeriPharma\u00ae Specialty Care\",\"description\":\"Specialty Care by AmeriPharma\",\"publisher\":{\"@id\":\"https:\\\/\\\/ameripharmaspecialty.com\\\/es\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/ameripharmaspecialty.com\\\/es\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"es\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/ameripharmaspecialty.com\\\/es\\\/#organization\",\"name\":\"Ameripharma Specialty Care\",\"url\":\"https:\\\/\\\/ameripharmaspecialty.com\\\/es\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"es\",\"@id\":\"https:\\\/\\\/ameripharmaspecialty.com\\\/es\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"https:\\\/\\\/ameripharmaspecialty.com\\\/wp-content\\\/uploads\\\/2024\\\/07\\\/specialty-care-logo-large-square.png\",\"contentUrl\":\"https:\\\/\\\/ameripharmaspecialty.com\\\/wp-content\\\/uploads\\\/2024\\\/07\\\/specialty-care-logo-large-square.png\",\"width\":400,\"height\":400,\"caption\":\"Ameripharma Specialty Care\"},\"image\":{\"@id\":\"https:\\\/\\\/ameripharmaspecialty.com\\\/es\\\/#\\\/schema\\\/logo\\\/image\\\/\"},\"sameAs\":[\"https:\\\/\\\/www.facebook.com\\\/ameripharma\\\/\"]},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/ameripharmaspecialty.com\\\/es\\\/#\\\/schema\\\/person\\\/1a08790136f47e0a1978629cdfeca933\",\"name\":\"Dr. Martina Mikail, PharmD\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"es\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/80314ccb70a255a42c79b579c4d8558683df0bb73c133efa5c0d8896353e2b79?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/80314ccb70a255a42c79b579c4d8558683df0bb73c133efa5c0d8896353e2b79?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/80314ccb70a255a42c79b579c4d8558683df0bb73c133efa5c0d8896353e2b79?s=96&d=mm&r=g\",\"caption\":\"Dr. Martina Mikail, PharmD\"},\"description\":\"Dr. Martina Mikail, PharmD was born in Egypt and raised in Pennsylvania and California. She graduated from Marshall B. Ketchum University in May 2022. Dr. Mikail is a recipent of the USPS Leadership Award and the CSHP Leadership Award, and is an active member of CSHP, ASHP, and APhA. The most rewarding part of her job is educating patients and counseling them on medications. In her free time, she likes to cook, spend time with family, and read.\",\"url\":\"https:\\\/\\\/ameripharmaspecialty.com\\\/es\\\/author\\\/martina-mikail\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"IgIV y enfermedad inflamatoria intestinal (EII) - AmeriPharma\u00ae Atenci\u00f3n especializada","description":"Este art\u00edculo analiza la IgIV y la enfermedad inflamatoria intestinal. Los temas incluyen c\u00f3mo la IgIV ayuda a controlar los s\u00edntomas, los efectos secundarios, los riesgos y m\u00e1s.","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/ameripharmaspecialty.com\/es\/other-health-conditions\/ivig-and-inflammatory-bowel-disease-ibd\/","og_locale":"es_MX","og_type":"article","og_title":"IVIG and Inflammatory Bowel Disease (IBD) - AmeriPharma\u00ae Specialty Care","og_description":"This article discusses IVIG and inflammatory bowel disease. Topics include how IVIG helps manage symptoms, side effects, risks, and more.","og_url":"https:\/\/ameripharmaspecialty.com\/es\/other-health-conditions\/ivig-and-inflammatory-bowel-disease-ibd\/","og_site_name":"AmeriPharma\u00ae Specialty Care","article_publisher":"https:\/\/www.facebook.com\/ameripharma\/","article_published_time":"2023-09-06T21:33:32+00:00","article_modified_time":"2026-03-24T16:57:02+00:00","og_image":[{"width":1280,"height":853,"url":"https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2023\/09\/ibd.jpg","type":"image\/jpeg"}],"author":"Dr. Martina Mikail, PharmD","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Dr. Martina Mikail, PharmD","Est. reading time":"6 minutos"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/ameripharmaspecialty.com\/zh\/other-health-conditions\/ivig-and-inflammatory-bowel-disease-ibd\/#article","isPartOf":{"@id":"https:\/\/ameripharmaspecialty.com\/zh\/other-health-conditions\/ivig-and-inflammatory-bowel-disease-ibd\/"},"author":{"name":"Dr. Martina Mikail, PharmD","@id":"https:\/\/ameripharmaspecialty.com\/es\/#\/schema\/person\/1a08790136f47e0a1978629cdfeca933"},"headline":"IVIG and Inflammatory Bowel Disease (IBD)","datePublished":"2023-09-06T21:33:32+00:00","dateModified":"2026-03-24T16:57:02+00:00","mainEntityOfPage":{"@id":"https:\/\/ameripharmaspecialty.com\/zh\/other-health-conditions\/ivig-and-inflammatory-bowel-disease-ibd\/"},"wordCount":1107,"publisher":{"@id":"https:\/\/ameripharmaspecialty.com\/es\/#organization"},"image":{"@id":"https:\/\/ameripharmaspecialty.com\/zh\/other-health-conditions\/ivig-and-inflammatory-bowel-disease-ibd\/#primaryimage"},"thumbnailUrl":"https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2023\/09\/ibd.jpg","keywords":["Dr. Martina Mikail"],"articleSection":["Other Health Conditions"],"inLanguage":"es"},{"@type":"WebPage","@id":"https:\/\/ameripharmaspecialty.com\/zh\/other-health-conditions\/ivig-and-inflammatory-bowel-disease-ibd\/","url":"https:\/\/ameripharmaspecialty.com\/zh\/other-health-conditions\/ivig-and-inflammatory-bowel-disease-ibd\/","name":"IgIV y enfermedad inflamatoria intestinal (EII) - AmeriPharma\u00ae Atenci\u00f3n especializada","isPartOf":{"@id":"https:\/\/ameripharmaspecialty.com\/es\/#website"},"primaryImageOfPage":{"@id":"https:\/\/ameripharmaspecialty.com\/zh\/other-health-conditions\/ivig-and-inflammatory-bowel-disease-ibd\/#primaryimage"},"image":{"@id":"https:\/\/ameripharmaspecialty.com\/zh\/other-health-conditions\/ivig-and-inflammatory-bowel-disease-ibd\/#primaryimage"},"thumbnailUrl":"https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2023\/09\/ibd.jpg","datePublished":"2023-09-06T21:33:32+00:00","dateModified":"2026-03-24T16:57:02+00:00","description":"Este art\u00edculo analiza la IgIV y la enfermedad inflamatoria intestinal. Los temas incluyen c\u00f3mo la IgIV ayuda a controlar los s\u00edntomas, los efectos secundarios, los riesgos y m\u00e1s.","breadcrumb":{"@id":"https:\/\/ameripharmaspecialty.com\/zh\/other-health-conditions\/ivig-and-inflammatory-bowel-disease-ibd\/#breadcrumb"},"inLanguage":"es","potentialAction":[{"@type":"ReadAction","target":["https:\/\/ameripharmaspecialty.com\/zh\/other-health-conditions\/ivig-and-inflammatory-bowel-disease-ibd\/"]}]},{"@type":"ImageObject","inLanguage":"es","@id":"https:\/\/ameripharmaspecialty.com\/zh\/other-health-conditions\/ivig-and-inflammatory-bowel-disease-ibd\/#primaryimage","url":"https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2023\/09\/ibd.jpg","contentUrl":"https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2023\/09\/ibd.jpg","width":1280,"height":853,"caption":"Intestine, colon, bowel in doctor hands. Digestive and gastrointestinal diseases concept."},{"@type":"BreadcrumbList","@id":"https:\/\/ameripharmaspecialty.com\/zh\/other-health-conditions\/ivig-and-inflammatory-bowel-disease-ibd\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/ameripharmaspecialty.com\/"},{"@type":"ListItem","position":2,"name":"IVIG and Inflammatory Bowel Disease (IBD)"}]},{"@type":"WebSite","@id":"https:\/\/ameripharmaspecialty.com\/es\/#website","url":"https:\/\/ameripharmaspecialty.com\/es\/","name":"Cuidado especializado AmeriPharma\u00ae","description":"Atenci\u00f3n especializada por AmeriPharma","publisher":{"@id":"https:\/\/ameripharmaspecialty.com\/es\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/ameripharmaspecialty.com\/es\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"es"},{"@type":"Organization","@id":"https:\/\/ameripharmaspecialty.com\/es\/#organization","name":"Atenci\u00f3n especializada de Ameripharma","url":"https:\/\/ameripharmaspecialty.com\/es\/","logo":{"@type":"ImageObject","inLanguage":"es","@id":"https:\/\/ameripharmaspecialty.com\/es\/#\/schema\/logo\/image\/","url":"https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2024\/07\/specialty-care-logo-large-square.png","contentUrl":"https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2024\/07\/specialty-care-logo-large-square.png","width":400,"height":400,"caption":"Ameripharma Specialty Care"},"image":{"@id":"https:\/\/ameripharmaspecialty.com\/es\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/www.facebook.com\/ameripharma\/"]},{"@type":"Person","@id":"https:\/\/ameripharmaspecialty.com\/es\/#\/schema\/person\/1a08790136f47e0a1978629cdfeca933","name":"Dra. Martina Mikail, PharmD","image":{"@type":"ImageObject","inLanguage":"es","@id":"https:\/\/secure.gravatar.com\/avatar\/80314ccb70a255a42c79b579c4d8558683df0bb73c133efa5c0d8896353e2b79?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/80314ccb70a255a42c79b579c4d8558683df0bb73c133efa5c0d8896353e2b79?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/80314ccb70a255a42c79b579c4d8558683df0bb73c133efa5c0d8896353e2b79?s=96&d=mm&r=g","caption":"Dr. Martina Mikail, PharmD"},"description":"La Dra. Martina Mikail, doctora en farmacia, naci\u00f3 en Egipto y creci\u00f3 en Pensilvania y California. Se gradu\u00f3 de la Universidad Marshall B. Ketchum en mayo de 2022. La Dra. Mikail ha recibido los Premios de Liderazgo del Servicio Postal de los Estados Unidos (USPS) y del CSHP, y es miembro activo de CSHP, ASHP y APhA. Lo m\u00e1s gratificante de su trabajo es educar a los pacientes y asesorarlos sobre sus medicamentos. En su tiempo libre, le gusta cocinar, pasar tiempo con su familia y leer.","url":"https:\/\/ameripharmaspecialty.com\/es\/author\/martina-mikail\/"}]}},"uagb_featured_image_src":{"full":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2023\/09\/ibd.jpg",1280,853,false],"thumbnail":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2023\/09\/ibd-150x150.jpg",150,150,true],"medium":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2023\/09\/ibd-300x200.jpg",300,200,true],"medium_large":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2023\/09\/ibd-768x512.jpg",768,512,true],"large":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2023\/09\/ibd-1024x682.jpg",1024,682,true],"1536x1536":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2023\/09\/ibd.jpg",1280,853,false],"2048x2048":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2023\/09\/ibd.jpg",1280,853,false],"trp-custom-language-flag":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2023\/09\/ibd.jpg",18,12,false],"block-image-html-large":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2023\/09\/ibd.jpg",600,400,false],"ct-gallery":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2023\/09\/ibd-330x220.jpg",330,220,true],"ct-section-header":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2023\/09\/ibd-1146x380.jpg",1146,380,true],"ct-thumb":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2023\/09\/ibd-86x57.jpg",86,57,true],"ct-thumb-large":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2023\/09\/ibd-167x111.jpg",167,111,true],"ct-small":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2023\/09\/ibd-280x187.jpg",280,187,true],"ct-medium":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2023\/09\/ibd-370x247.jpg",370,247,true],"ct-xmedium":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2023\/09\/ibd-960x640.jpg",960,640,true],"ct-large":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2023\/09\/ibd.jpg",1280,853,false]},"uagb_author_info":{"display_name":"Dr. Martina Mikail, PharmD","author_link":"https:\/\/ameripharmaspecialty.com\/es\/author\/martina-mikail\/"},"uagb_comment_info":0,"uagb_excerpt":"IVIG, also known as intravenous immunoglobulin, is a drug therapy that contains a mixture of concentrated human-derived antibodies. It is used for a variety of conditions, including autoimmune disorders and immune deficiencies in which the body doesn't produce sufficient healthy antibodies or destroys its own antibodies.","rttpg_featured_image_url":{"full":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2023\/09\/ibd.jpg",1280,853,false],"landscape":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2023\/09\/ibd.jpg",1280,853,false],"portraits":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2023\/09\/ibd.jpg",1280,853,false],"thumbnail":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2023\/09\/ibd-150x150.jpg",150,150,true],"medium":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2023\/09\/ibd-300x200.jpg",300,200,true],"large":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2023\/09\/ibd-1024x682.jpg",1024,682,true],"1536x1536":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2023\/09\/ibd.jpg",1280,853,false],"2048x2048":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2023\/09\/ibd.jpg",1280,853,false],"trp-custom-language-flag":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2023\/09\/ibd.jpg",18,12,false],"block-image-html-large":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2023\/09\/ibd.jpg",600,400,false],"ct-gallery":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2023\/09\/ibd-330x220.jpg",330,220,true],"ct-section-header":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2023\/09\/ibd-1146x380.jpg",1146,380,true],"ct-thumb":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2023\/09\/ibd-86x57.jpg",86,57,true],"ct-thumb-large":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2023\/09\/ibd-167x111.jpg",167,111,true],"ct-small":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2023\/09\/ibd-280x187.jpg",280,187,true],"ct-medium":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2023\/09\/ibd-370x247.jpg",370,247,true],"ct-xmedium":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2023\/09\/ibd-960x640.jpg",960,640,true],"ct-large":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2023\/09\/ibd.jpg",1280,853,false]},"rttpg_author":{"display_name":"Dr. Martina Mikail, PharmD","author_link":"https:\/\/ameripharmaspecialty.com\/es\/author\/martina-mikail\/"},"rttpg_comment":0,"rttpg_category":"<a href=\"https:\/\/ameripharmaspecialty.com\/es\/category\/other-health-conditions\/\" rel=\"category tag\">Other Health Conditions<\/a>","rttpg_excerpt":"IVIG, also known as intravenous immunoglobulin, is a drug therapy that contains a mixture of concentrated human-derived antibodies. It is used for a variety of conditions, including autoimmune disorders and immune deficiencies in which the body doesn't produce sufficient healthy antibodies or destroys its own antibodies.","_links":{"self":[{"href":"https:\/\/ameripharmaspecialty.com\/es\/wp-json\/wp\/v2\/posts\/23280","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/ameripharmaspecialty.com\/es\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/ameripharmaspecialty.com\/es\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/ameripharmaspecialty.com\/es\/wp-json\/wp\/v2\/users\/16"}],"replies":[{"embeddable":true,"href":"https:\/\/ameripharmaspecialty.com\/es\/wp-json\/wp\/v2\/comments?post=23280"}],"version-history":[{"count":0,"href":"https:\/\/ameripharmaspecialty.com\/es\/wp-json\/wp\/v2\/posts\/23280\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/ameripharmaspecialty.com\/es\/wp-json\/wp\/v2\/media\/23282"}],"wp:attachment":[{"href":"https:\/\/ameripharmaspecialty.com\/es\/wp-json\/wp\/v2\/media?parent=23280"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/ameripharmaspecialty.com\/es\/wp-json\/wp\/v2\/categories?post=23280"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/ameripharmaspecialty.com\/es\/wp-json\/wp\/v2\/tags?post=23280"}],"curies":[{"name":"gracias","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}